Nicox SA (OTCMKTS:NICXF) Sees Large Increase in Short Interest

Nicox SA (OTCMKTS:NICXF) saw a large growth in short interest in March. As of March 13th, there was short interest totaling 421 shares, a growth of 1,904.8% from the February 26th total of 21 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days. Currently, 0.0% of the shares of the company are short sold. Currently, 0.0% of the shares of the company are short sold. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Nicox Price Performance

Shares of NICXF stock remained flat at $0.30 during trading hours on Tuesday. The firm has a 50-day moving average price of $0.30 and a two-hundred day moving average price of $0.30. Nicox has a one year low of $0.25 and a one year high of $0.30.

Nicox Company Profile

Nicox is a global biopharmaceutical company focused on the research, development and commercialization of innovative treatments for eye diseases. The company’s therapeutic approach centers on nitric oxide–donating compounds and anti-inflammatory agents designed to address glaucoma, ocular surface disorders and allergic eye conditions. With a pipeline spanning pre-clinical to late-stage clinical programs, Nicox aims to bring new modalities to market that target unmet needs in ophthalmology.

The company’s lead commercial product, ZERVIATE® (ciclesonide ophthalmic solution), is indicated for the relief of ocular itching associated with allergic conjunctivitis.